This AASLD 2018 Hepatitis B Guidance is intended to complement the AASLD 2016
Practice Guidelines for Treatment of Chronic Hepatitis B (1) and update the previous …

Summary Background The 69th World Health Assembly approved the Global Health Sector
Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis …

Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …

Background With recent improvements in vaccines and treatments against viral hepatitis, an
improved understanding of the burden of viral hepatitis is needed to inform global …

Hepatitis B virus (HBV) is transmitted via blood or sexual contact. Persons with chronic HBV
infection are at increased risk for cirrhosis and liver cancer and require medical care. This …

OBJECTIVE: Chronic hepatitis B virus infection is one of the most serious infections and a
major risk factor for deaths from cirrhosis and liver cancer. We estimate age-, sex-and region …

These guidelines have been written to assist physicians and other health care providers in
the recognition, diagnosis, and management of patients chronically infected with the …

Hepadnaviruses (hepatitis B viruses) cause transient and chronic infections of the liver.
Transient infections run a course of several months, and chronic infections are often lifelong …

Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV)
infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and …

Since the introduction of the hepatitis B vaccine and other preventive measures, the
worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains …